2009
DOI: 10.1007/s00701-009-0350-1
|View full text |Cite
|
Sign up to set email alerts
|

Elevated level of endothelin-1 in cerebrospinal fluid and lack of nitric oxide in basilar arterial plasma associated with cerebral vasospasm after subarachnoid haemorrhage in rabbits

Abstract: This study demonstrates that an elevated ET-1 level in CSF and local lack of NO in the basilar arterial plasma samples are associated with CVS after experimental SAH.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
18
0

Year Published

2010
2010
2014
2014

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(18 citation statements)
references
References 36 publications
(87 reference statements)
0
18
0
Order By: Relevance
“…The NO levels in plasma and cerebrospinal fluid after SAH have a major impact on the CVS occurrence or not [31,32]. The oxyhemoglobin released from the coagulation in subarachnoid can inhibit eNOS of the adventitia of spasmodic blood vessel and inhibit the synthesis of NO after SAH.…”
Section: Discussionmentioning
confidence: 99%
“…The NO levels in plasma and cerebrospinal fluid after SAH have a major impact on the CVS occurrence or not [31,32]. The oxyhemoglobin released from the coagulation in subarachnoid can inhibit eNOS of the adventitia of spasmodic blood vessel and inhibit the synthesis of NO after SAH.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, exogenous ET-1 is able to decrease CBF to levels that induce ischemia (Macrae et al, 1993). After both ischemic stroke and SAH, the levels of ET-1 are increased in plasma, cerebrospinal fluid, and cerebral tissue (Lampl et al, 1997;Neuschmelting et al, 2009;Thampatty et al, 2011;Viossat et al, 1993), and although the detected levels are lower than the ones necessary to cause vasoconstriction under normal conditions, increased ET-1 sensitivity of cerebral arteries due to receptor upregulation may allow secreted ET-1 to cause detrimental cerebral vasoconstriction. However, attempts to treat ischemic stroke with specific ET receptor antagonists have produced conflicting results.…”
Section: Ischemic Strokementioning
confidence: 99%
“…aggregation and vascular tone. This is similar to the wellestablished dichotomy between ET-1 and the vasodilator nitric oxide (NO), where downregulation of NO is potentially accompanied by ET-1 upregulation resulting in vasoconstriction (Neuschmelting et al, 2009). The enzymes on the lipoxygenase side of the eicosanoid pathway are also induced (Alox5, Alox12, Alox15 and Alox5ap), with no previously documented effects by ET-1 directly.…”
Section: Discussionmentioning
confidence: 71%